Genmab Launches AI Everywhere Initiative with ChatGPT Enterprise
With a legacy spanning 25 years, the Danish biotech firm Genmab has recently expanded significantly. Their focus on developing next-generation antibody therapies for cancer and other serious diseases necessitates handling vast amounts of data. To address this, they adopted ChatGPT Enterprise soon after OpenAI launched this subscription plan, which offers enhanced security, privacy, advanced data analysis […]
Genmab Launches AI Everywhere Initiative with ChatGPT Enterprise Read More »